Erythromycin reduces nasal inflammation by inhibiting immunoglobulin production, attenuating mucus secretion, and modulating cytokine expression
Abstract Allergic rhinitis (AR) and chronic rhinosinusitis (CRS) share some similar pathological mechanisms. In current study, we intend to investigate the impact of AR on CRS. In addition, we explored the efficacy of erythromycin (EM) treatment on CRS mice with or without AR (CRSwoAR, CRSwAR). Stud...
Guardado en:
Autores principales: | Ting-Ting Yen, Rong-San Jiang, Ching-Yun Chang, Chih-Ying Wu, Kai-Li Liang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1ac077b3505a4951a9c3a19e2b3950bd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effect of Erythromycin on the Intestinal Transport of Cyclosporine
por: P Zakeri Milani,, et al.
Publicado: (2009) -
Cytokine Storm and Mucus Hypersecretion in COVID-19: Review of Mechanisms
por: Khan MA, et al.
Publicado: (2021) -
AGR2, an endoplasmic reticulum protein, is secreted into the gastrointestinal mucus.
por: Joakim H Bergström, et al.
Publicado: (2014) -
Astrovirus infects actively secreting goblet cells and alters the gut mucus barrier
por: Valerie Cortez, et al.
Publicado: (2020) -
Cyclodextrin-erythromycin complexes as a drug delivery device for orthopedic application
por: Song W, et al.
Publicado: (2011)